DOI:
10.1055/s-00000075
Seminars in Respiratory and Critical Care Medicine
LinksClose Window
References
O'Byrne PM, Metev H, Puu M. , et al.
Efficacy and safety of a CXCR2 antagonist, AZD5069, in patients with uncontrolled persistent asthma: a randomised, double-blind, placebo-controlled trial.
Lancet Respir Med 2016;
4 (10) 797-806
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.